share_log

康哲藥業:截至二零二四年六月三十日止年度之中期股息

CMS: INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2024

HKEX ·  Aug 15 10:15
Summary by Moomoo AI
康哲藥業(CMS)於2024年8月15日宣布,將派發截至2024年6月30日止六個月的中期股息。每股股息為0.1507人民幣,折合香港幣為0.164元,按照1人民幣兌1.0914港幣的匯率計算。股息除淨日定於2024年8月29日,而股份過戶登記將於2024年9月2日暫停一天。記錄日期為同日,股息派發日則訂於2024年9月9日。本次股息派發不需股東批准,公司董事會成員包括執行董事林剛先生及陳燕玲女士,非執行董事陳洪兵先生,以及獨立非執行董事梁創順先生、羅瑩女士及馮征先生。
康哲藥業(CMS)於2024年8月15日宣布,將派發截至2024年6月30日止六個月的中期股息。每股股息為0.1507人民幣,折合香港幣為0.164元,按照1人民幣兌1.0914港幣的匯率計算。股息除淨日定於2024年8月29日,而股份過戶登記將於2024年9月2日暫停一天。記錄日期為同日,股息派發日則訂於2024年9月9日。本次股息派發不需股東批准,公司董事會成員包括執行董事林剛先生及陳燕玲女士,非執行董事陳洪兵先生,以及獨立非執行董事梁創順先生、羅瑩女士及馮征先生。
CMS announced on August 15, 2024 that it will distribute mid-term dividends for the six months ending on June 30, 2024. The dividend per share is RMB 0.1507, equivalent to HKD 0.164, calculated at the exchange rate of 1 RMB to 1.0914 HKD. The ex-dividend date is scheduled for August 29, 2024, and share transfer registration will be suspended for one day on September 2, 2024. The record date is the same day, and the dividend payment date is set for September 9, 2024. Shareholders' approval is not required for the dividend payment. Members of the company's board of directors include executive director Mr. Lin Gang and Ms. Chen Yanling, non-executive director Mr. Chen Hongbing, and independent non-executive directors Mr. Leung Chong-shun, Ms. Luo Ying, and Mr. Feng Zheng.
CMS announced on August 15, 2024 that it will distribute mid-term dividends for the six months ending on June 30, 2024. The dividend per share is RMB 0.1507, equivalent to HKD 0.164, calculated at the exchange rate of 1 RMB to 1.0914 HKD. The ex-dividend date is scheduled for August 29, 2024, and share transfer registration will be suspended for one day on September 2, 2024. The record date is the same day, and the dividend payment date is set for September 9, 2024. Shareholders' approval is not required for the dividend payment. Members of the company's board of directors include executive director Mr. Lin Gang and Ms. Chen Yanling, non-executive director Mr. Chen Hongbing, and independent non-executive directors Mr. Leung Chong-shun, Ms. Luo Ying, and Mr. Feng Zheng.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more